✦ LIBER ✦

Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV-Infected Adults: A Randomized, Double-Blind, Phase 1b Study

✍ Scribed by Sulkowski, M. S.; Kang, M.; Matining, R.; Wyles, D.; Johnson, V. A.; Morse, G. D.; Amorosa, V.; Bhattacharya, D.; Coughlin, K.; Wong-Staal, F.; Glesby, M. J.

Book ID: 121692837
Publisher: University of Chicago Press
Year: 2013
Tongue: English
Weight: 338 KB
Volume: 209
Category: Article
ISSN: 0022-1899
DOI: 10.1093/infdis/jit503

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

31 SAFETY AND ANTIVIRAL ACTIVITY OF THE

31 SAFETY AND ANTIVIRAL ACTIVITY OF THE HCV NON-NUCLEOSIDE POLYMERASE INHIBITOR VX-222 IN TREATMENT-NAIVE GENOTYPE 1 HCV-INFECTED PATIENTS

✍ M. Rodriguez-Torres; E. Lawitz; B. Conway; K. Kaita; A.M. Sheikh; R. Ghalib; R. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

1186 SAFETY AND ANTIVIRAL ACTIVITY OF AB

1186 SAFETY AND ANTIVIRAL ACTIVITY OF ABT-267, A NOVEL NS5A INHIBITOR, DURING 3-DAY MONOTHERAPY: FIRST STUDY IN HCV GENOTYPE-1 (GT1)-INFECTED TREATMENT-NAIVE SUBJECTS

✍ Lawitz, E.; Marbury, T.; Campbell, A.; Dumas, E.; Kapoor, M.; Pilot-Matias, T.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 118 KB

941 JTK-652 IS A NOVEL HCV ENTRY INHIBIT

941 JTK-652 IS A NOVEL HCV ENTRY INHIBITOR: RESULTS OF A PHASE 1 STUDY EVALUATING SAFETY, TOLERABILITY AND ANTIVIRAL ACTIVITY IN CHRONIC HEPATITIS C PATIENTS

✍ J. de Bruijne; J. Bergmann; C. Weegink; K. van Nieuwkerk; R. de Knegt; J. van de 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

64 SAFETY OF THE HCV PROTEASE INHIBITOR

64 SAFETY OF THE HCV PROTEASE INHIBITOR TMC435350 IN HEALTHY VOLUNTEERS AND SAFETY AND ACTIVITY IN CHRONIC HEPATITIS C INFECTED INDIVIDUALS: A PHASE I STUDY

✍ H. Reesink; R. Verloes; K. Abou Farha; A. Van Vliet; C. Weegink; G. van 't Kloos 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 72 KB

561 Safety and pharmacokinetics of the n

561 Safety and pharmacokinetics of the now nucleoside polymerase inhibitor, HCV-796: Results of a randomized, double-blind, placebo-controlled, ascending single-dose study in healthy subjects

✍ P. Chandra; D. Raible; L. Moyer; D. Harper; J. Speth; S. Villano; R. Fruncillo 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Efficacy and safety of rilpivirine in tr

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials

✍ Nelson, M.; Amaya, G.; Clumeck, N.; Arns da Cunha, C.; Jayaweera, D.; Junod, P.; 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 261 KB